Catalyst Pharmaceuticals (CPRX) Inventory Average (2019 - 2026)
Catalyst Pharmaceuticals (CPRX) posted Inventory Average of $36.0 million for Q1 2026, up 10.59% on a QoQ basis from $32.6 million in Q4 2025, and up 83.36% year-over-year from $19.7 million in Q1 2025.
Catalyst Pharmaceuticals (CPRX) Inventory Average (2019 - 2026) Analysis & Trends
Catalyst Pharmaceuticals' Inventory Average history runs 8 years deep, the most recent figure standing at $36.0 million for Q1 2026.
- Quarterly Inventory Average rose 83.36% year-over-year to $36.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $36.0 million (up 83.36% YoY) and the FY2025 annual result came in at $28.4 million, up 61.17% from the prior year.
- Inventory Average was $36.0 million for Q1 2026 at Catalyst Pharmaceuticals, up from $32.6 million in the prior quarter.
- Across five years, Inventory Average topped out at $36.0 million in Q1 2026 and bottomed at $7.0 million in Q4 2022.
- A 5-year average of $16.3 million and a median of $17.8 million in 2024 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2022 — Inventory Average decreased 5.96% — and 2024, when it soared 107.77%.
- Catalyst Pharmaceuticals' Inventory Average stood at $7.0 million in 2022, then soared by 77.08% to $12.3 million in 2023, then surged by 60.29% to $19.8 million in 2024, then surged by 64.81% to $32.6 million in 2025, then advanced by 10.59% to $36.0 million in 2026.
- Business Quant data shows CPRX's Inventory Average at $36.0 million in Q1 2026, $32.6 million in Q4 2025, and $23.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 644.91 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.15 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn | 36.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.05 Mn |
| Dec 31, 2025 | 32.60 Mn |
| Sep 30, 2025 | 23.34 Mn |
| Jun 30, 2025 | 19.21 Mn |
| Mar 31, 2025 | 19.66 Mn |
| Dec 31, 2024 | 19.78 Mn |
| Sep 30, 2024 | 19.02 Mn |
| Jun 30, 2024 | 18.98 Mn |
| Mar 31, 2024 | 17.80 Mn |
| Dec 31, 2023 | 12.34 Mn |
| Sep 30, 2023 | 9.89 Mn |
| Jun 30, 2023 | 10.54 Mn |
| Mar 31, 2023 | 8.57 Mn |
| Dec 31, 2022 | 6.97 Mn |
| Sep 30, 2022 | 7.49 Mn |
| Jun 30, 2022 | 7.84 Mn |
| Mar 31, 2022 | 7.85 Mn |
| Dec 31, 2021 | 7.41 Mn |
| Sep 30, 2021 | 7.02 Mn |
| Jun 30, 2021 | 5.74 Mn |